Idera Pharmaceuticals, Inc.

NASDAQ:IDRA  
0.68
+0.04 (+6.26%)
Earnings Announcements

Idera Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update

Published: 03/31/2022 21:08 GMT
Idera Pharmaceuticals, Inc. (IDRA) - Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
Q4 Loss per Share $0.08.
Cash Position As of December 31, 2021 Was $32.5 Million.
Idera - Sees Current Cash Position to Fund Operations Through One-year Period Subsequent to March 31, 2022 Filing Date of Annual Report Form 10-k.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.